Clinical trial · Observational
A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
Infantile Hemangioma Tumor Size and C/T Polymorphism Within CTCF Binding Site Six
NCT00974129CI-TRIAL-00014925withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): no subjects were enrolled, study was halted due to study staff departure
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the genotype of CTCF, a proven transcription factor, in patients with infantile hemangiomas and to monitor tumor growth. The investigators aim to determine whether or not the CTCF genotype might serve as an early and reliable predictor of tumor growth.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hemangioma | Hemangioma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Patients with Infantile Hemangiomas
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 1 Year
Show eligibility criteria text
Inclusion Criteria: * Hemangioma must appear within one month prior to enrollment Exclusion Criteria: * Hemangioma appeared before one month prior to enrollment
References
Publications (0)
Data not yet available
No reference posted for this study.